{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T01:06:53Z","timestamp":1774573613748,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.biopha.2018.04.120","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T12:31:25Z","timestamp":1525696285000},"page":"1272-1278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2\/9 through the PI3K\/Akt signaling pathway"],"prefix":"10.1016","volume":"103","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixue","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xilin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.04.120_bib0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrc1429","article-title":"Gallbladder cancer: lessons from a rare tumour","volume":"4","author":"II","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2018.04.120_bib0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2018.04.120_bib0015","first-page":"221","article-title":"Gallbladder cancer","volume":"3","author":"Raki\u0107","year":"2014","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.biopha.2018.04.120_bib0020","first-page":"215","article-title":"Facing the challenge of treating gallbladder carcinoma. Review of the literature","volume":"57","author":"Mastoraki","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.biopha.2018.04.120_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.suronc.2012.08.002","article-title":"Gallbladder cancer: past, present and an uncertain future","volume":"21","author":"Boutros","year":"2012","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.biopha.2018.04.120_bib0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjsurg.2007.11.011","volume":"196","author":"Gourgiotis","year":"2008","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.biopha.2018.04.120_bib0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1186\/1471-2407-14-566","article-title":"Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study","volume":"14","author":"Shu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2018.04.120_bib0040","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1245\/s10434-013-3292-z","article-title":"Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma","volume":"21","author":"Wu","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.biopha.2018.04.120_bib0045","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00000658-199611000-00008","article-title":"Long-term results after resection for gallbladder cancer. Implications for staging and management","volume":"224","author":"Bartlett","year":"1996","journal-title":"Ann. Surg."},{"key":"10.1016\/j.biopha.2018.04.120_bib0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00268-002-6702-0","article-title":"Hepatoduodenal ligament invasion by gallbladder carcinoma: histologic patterns and surgical recommendation","volume":"27","author":"Kaneoka","year":"2003","journal-title":"World J. Surg."},{"key":"10.1016\/j.biopha.2018.04.120_bib0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/1471-2148-8-225","article-title":"Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties","volume":"8","author":"Bianca","year":"2008","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.biopha.2018.04.120_bib0060","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/bies.20304","article-title":"TRIM\/RBCC, a novel class of\u2019 single protein RING finger\u2019 E3 ubiquitin ligases","volume":"27","author":"Meroni","year":"2005","journal-title":"Bioessays"},{"key":"10.1016\/j.biopha.2018.04.120_bib0065","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature13955","article-title":"TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein","volume":"516","author":"Bhatnagar","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.04.120_bib0070","doi-asserted-by":"crossref","first-page":"40106","DOI":"10.1074\/jbc.M112.380865","article-title":"Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1\/E2F interactions","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.04.120_bib0075","first-page":"1544","article-title":"TRIM6 interacts with Myc and maintains the pluripotency of mouse embryonic stem cells","volume":"125","author":"Sato","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biopha.2018.04.120_bib0080","doi-asserted-by":"crossref","first-page":"e1004533","DOI":"10.1371\/journal.pgen.1004533","article-title":"The TRIM-NHL protein LIN-41 controls the onset of developmental plasticity in Caenorhabditis elegans","volume":"10","author":"Tocchini","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.biopha.2018.04.120_bib0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-11-24","article-title":"Regulatory role of TRIM21 in the type-I interferon pathway in Japanese encephalitis virus-infected human microglial cells","volume":"11","author":"Manocha","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2018.04.120_bib0090","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/jcb.21908","article-title":"Characterization of TRIM31, upregulated in gastric adenocarcinoma, as a novel RBCC protein","volume":"105","author":"Sugiura","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2018.04.120_bib0095","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1007\/s13277-014-1763-x","article-title":"TRIM31 is downregulated in non-small cell lung cancer and serves as a potential tumor suppressor","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.biopha.2018.04.120_bib0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yexcr.2016.09.022","article-title":"Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2","volume":"349","author":"Chen","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2018.04.120_bib0105","first-page":"803","article-title":"GKN2 increases apoptosis, reduces the proliferation and invasion ability of gastric cancer cells through down-regulating the JAK\/STAT signaling pathway","volume":"9","author":"Ouyang","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2018.04.120_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-014-0276-y","article-title":"SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K\/AKT pathway","volume":"14","author":"Shu","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2018.04.120_bib0115","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3892\/ijo.2017.4081","article-title":"Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K\/AKT pathway","volume":"51","author":"Hao","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2018.04.120_bib0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1475-2867-13-64","article-title":"Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells","volume":"13","author":"Liu","year":"2013","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2018.04.120_bib0125","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/bies.20304","article-title":"TRIM\/RBCC, a novel class of 'single protein RING finger’ E3 ubiquitin ligases","volume":"27","author":"Meroni","year":"2005","journal-title":"Bioessays"},{"key":"10.1016\/j.biopha.2018.04.120_bib0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12032-016-0842-9","article-title":"Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer","volume":"33","author":"Wei","year":"2016","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2018.04.120_bib0135","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/onc.2017.349","article-title":"TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex","volume":"37","author":"Guo","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2018.04.120_bib0140","doi-asserted-by":"crossref","first-page":"18753","DOI":"10.1074\/jbc.M802530200","article-title":"A novel binding factor of 14-3-3beta functions as a transcriptional repressor and promotes anchorage-independent growth, tumorigenicity, and metastasis","volume":"283","author":"Komiya","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.04.120_bib0145","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2018.04.120_bib0150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00432-014-1803-3","article-title":"Current clinical regulation of PI3K\/PTEN\/Akt\/mTOR signalling in treatment of human cancer","volume":"141","author":"Hui","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.biopha.2018.04.120_bib0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156800908784293659","article-title":"The PTEN\/PI3K\/AKT signalling pathway in cancer, therapeutic implications","volume":"8","author":"Carnero","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.biopha.2018.04.120_bib0160","first-page":"4068","article-title":"Upregulation of long non-coding RNA LINC00152 by SP1 contributes to gallbladder cancer cell growth and tumor metastasis via PI3K\/AKT pathway","volume":"8","author":"Cai","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2018.04.120_bib0165","doi-asserted-by":"crossref","first-page":"19980","DOI":"10.18632\/oncotarget.15301","article-title":"SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt\/mTOR signaling","volume":"8","author":"Qin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.04.120_bib0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2015.01.041","article-title":"Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer","volume":"360","author":"Cao","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2018.04.120_bib0175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.drup.2007.11.003","article-title":"Targeting the PI3K\/Akt\/mTOR pathway: effective combinations and clinical considerations","volume":"11","author":"Lopiccolo","year":"2008","journal-title":"Drug Resist. Updat."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218316378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218316378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T01:57:45Z","timestamp":1720663065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218316378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":35,"alternative-id":["S0753332218316378"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.04.120","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2\/9 through the PI3K\/Akt signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.04.120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}